NCT05560022
Withdrawn
Not Applicable
Study of the Total Hip Prosthesis With a HYPE Stem in Hip Arthroplasty
Societe dEtude, de Recherche et de Fabrication2 sites in 1 country180 target enrollmentDecember 5, 2017
ConditionsHip Arthropathy
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Hip Arthropathy
- Sponsor
- Societe dEtude, de Recherche et de Fabrication
- Enrollment
- 180
- Locations
- 2
- Primary Endpoint
- Assess the Survival rate to Total Hip Prothesis combining a HYPE stem and a SERF cup in hip replacements
- Status
- Withdrawn
- Last Updated
- 8 days ago
Overview
Brief Summary
The purpose of this study is to validate the performance and the safety of the HYPE (SERF) prothesis in compliance with the 93/42/EEC directive and in relation to the recommendations of the MEDDEV 2.7.1 guide ( guideline for post-market follow-up), which provides for the implementation of a systematic procedure for the follow-up of clinical data in order to verify the performance claimed for medical devices .
Investigators
Eligibility Criteria
Inclusion Criteria
- •Man or women
- •Degenerative or inflammatory hip pathology requiring a total hip replacement
- •Primary or secondary osteoarthritis
- •Advanced joint destruction resulting from rhumatoid arthritis or traumatic arthritis
- •Fracture or avascular necrosis
- •Sub-capital fracture and displaced transcervical as well as for bone defects stages I to IIb of PAPROSKY
- •Traumatic joint destruction
- •Following previous intervention, provided that the new device does not interfere with the material in place (osteosynthesis, joint reconstruction, arthrodesis, hemi-arthroplasty, total arthroplasty
Exclusion Criteria
- •People with diminished mental faculties
- •Known current pregnancy
- •Breast-feeding
- •Neurological disorders or other pathologies that may influence locomotion
- •Septic antecedent on hip to operate
- •Patient requiring a bone graft
Outcomes
Primary Outcomes
Assess the Survival rate to Total Hip Prothesis combining a HYPE stem and a SERF cup in hip replacements
Time Frame: per operative period to 10 years
Survival according to Kaplan Meier
Secondary Outcomes
- Assess the improvement in PMA scores and HHS score as well as patient satisfaction(per operative period to 10 years)
- Adverse events(per operative period to 10 years)
- Patient satisfaction(per operative period to 10 years)
Study Sites (2)
Loading locations...
Similar Trials
Active, not recruiting
Not Applicable
Assessment of Safety and Performances of HYPE Stems Associated to a SERF Acetabular Cup in Hip Arthroplasty (2017-01-NH)Hip ArthropathyNCT05524350Societe dEtude, de Recherche et de Fabrication180
Terminated
Not Applicable
Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone CementOsteoarthritis, HipTraumatic Arthritis of HipNCT00588861Biomet Orthopedics, LLC400
Completed
Not Applicable
The Metaphyseal Hip Prosthesis - Total HipOsteoarthritis of the HipNCT01501955Zimmer Biomet20
Terminated
Not Applicable
Secur-Fit Advanced Outcomes StudyArthroplasty, Replacement, HipNCT01917929Stryker Orthopaedics326
Completed
Not Applicable
Anthology Hip Replacement System - Orthopaedic Data Evolution Panel (ODEP) Surveillance StudyPrimary OsteoarthritisSecondary OsteoarthritisAvascular NecrosisPrimary Total Hip Replacement (THR)NCT04425603Smith & Nephew Orthopaedics AG270